Klaria Pharma Holding AB (publ.) (STO:KLAR)

STO:KLAR Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	145	48	49	69	320	326
Market Cap Growth	-1.44%	-1.44%	-28.31%	-78.53%	-1.82%	133.40%
Enterprise Value	169	48	47	63	294	306
Last Close Price	1.00	0.34	0.46	1.16	5.79	5.81
PS Ratio	64.39	21.57	-	11.70	52.30	45.10
PB Ratio	43.80	14.66	1.20	0.90	4.61	2.97
P/TBV Ratio	-	-	1.20	-	-	31.11
EV/Sales Ratio	75.00	21.33	-	10.70	48.07	42.44
Debt / Equity Ratio	-	-	0.46	0.24	0.46	0.09
Asset Turnover	0.04	0.04	-	0.05	0.05	0.06
Quick Ratio	0.05	0.05	0.07	0.47	0.57	1.43
Current Ratio	0.05	0.05	2.29	0.93	0.58	1.45
Return on Equity (ROE)	-214.89%	-214.89%	-61.06%	-87.66%	-59.81%	-53.66%
Return on Assets (ROA)	-29.96%	-29.96%	-9.50%	-29.05%	-40.37%	-26.12%
Return on Capital (ROIC)	-61.55%	-61.55%	-11.89%	-35.47%	-45.80%	-28.75%
Earnings Yield	-32.99%	-98.47%	-72.73%	-92.92%	-16.75%	-15.80%
FCF Yield	-	-24.61%	-6.84%	-72.52%	-7.76%	-10.85%
Buyback Yield / Dilution	-23.63%	-23.63%	-73.49%	-12.15%	-19.58%	-39.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.